STRUCTURE AND PROCESSING OF TRYPANOSOME VARIANT ANTIGENS
锥虫变异抗原的结构和加工
基本信息
- 批准号:3131702
- 负责人:
- 金额:$ 23.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-08-01 至 1992-07-31
- 项目状态:已结题
- 来源:
- 关键词:Trypanosoma aspartate chemical structure ethanolamines fatty acids gas chromatography gene expression genetic translation glycolipids high performance liquid chromatography immunological substance lipid solubility mass spectrometry microorganism growth nuclear magnetic resonance spectroscopy protozoal antigen surface antigens trypanosomiasis
项目摘要
Human and animal-infective trypanosomes have major medical
and veterinary consequences for equatorial Africa. Failure of the
immune system to eliminate trypanosome infections is largely
attributable to the Salivarian trypanosomes' unique mechanism for
antigenic variations. Each trypanosome is covered by a surface
coat consisting of a closely packed monolayer of about ten million
molecules of a single member of a large family of variant surface
glycoproteins (VSGs). The aim of this proposal is to study the
carboxy-terminal post-translational modification of the VSGs of
Trypanosoma brucei, whereby a hydrophobic peptide tail, present
on the primary VSG mRNA translation product, is cleaved and
replaced by a complex glycan inositol phospholipid, which anchors
VSG to the surface membrane. The question of variable
galactosylation of the VSG-linked glycolipid will be resolved by
extending structural at a glycolipid having several of teh
characteristic expected of an immediate precursor of the VSG-
linked glycolipid will be determined, suing the previously
characterized VSG-linked as a model for experimental design and
methodology. There are indications that peptide as a model for
experimental design and methodology. There are indications that
peptide cleavage and glycolipid attachment occur in a co-
ordinated reaction at the endoplasmic reticulum, but that further
processing of the glycan side-chain may occur in the Golgi
apparatus. Cell-free systems will be developed, using
trypanosome microsomal fractions, in which details of the
modification reaction can be investigated. A further aim of this
proposal is to investigate the role of the glycolipid moiety in VSG
secretion, function, turnover and release. Conceptual and
experimental contributions to these aspects can be expected from
the expanding awareness of similar post-translational
modification of several mammalian proteins. Since trypanosomes
attach glycolipid to 10% of their protein (the VSG), they may
represent the ideal model in which to explore some aspects of a
modification pathway that may be important to all eukaryotic
cells. The VSG-releasing enzyme, a glycan-phosphatidylinositol-
specific phospholipase C (GPI-PLC), will be further characterized.
Further specificity studies will be performed, its subcellular
location will be determined, and the regulation of its activity by
effectors and inhibitors will be determined. The GPI-PLC gene
will be cloned and sequenced, for studies of its biosynthesis,
regulation, and to facilitate characterization of the corresponding
mammalian enzyme.
感染人类和动物的锥虫具有重要的医学意义
以及对赤道非洲的兽医影响。 失败
免疫系统消除锥虫感染,
由于唾液锥虫的独特机制,
抗原变异 每一个锥虫都被一个表面所覆盖
由大约一千万个紧密堆积的单层组成的被毛
变体表面大家族的单个成员的分子
糖蛋白(VSG)。 这项建议的目的是研究
VSG的羧基末端翻译后修饰
布氏锥虫,其中存在疏水肽尾,
在初级VSG mRNA翻译产物上,被切割,
被一种复合的聚糖肌醇磷脂所取代,
VSG到表面膜。 变量的问题
VSG连接的糖脂的半乳糖基化将通过
在糖脂处延伸结构,
预期VSG的直接前体的特征-
连接糖脂将被确定,使用以前的
其特征在于VSG连接作为实验设计的模型,
方法论 有迹象表明,肽作为模型,
实验设计和方法。 有迹象表明
肽裂解和糖脂附着发生在共-
在内质网的协调反应,但进一步
聚糖侧链的加工可能发生在高尔基体中,
设备. 将开发无细胞系统,
锥虫微粒体组分,其中的细节
可以研究改性反应。 其进一步的目的是
一个建议是研究糖脂部分在VSG中的作用
分泌、功能、周转和释放。 概念和
这些方面的实验贡献,可以预期从
对类似的翻译后
几种哺乳动物蛋白质的修饰。 自从锥虫
将糖脂附着在10%的蛋白质(VSG)上,
代表了一个理想的模型,在这个模型中,
修饰途径,可能是重要的所有真核生物
细胞 VSG释放酶,一种聚糖磷脂酰肌醇,
特异性磷脂酶C(GPI-PLC)将进一步表征。
将进行进一步的特异性研究,其亚细胞
将确定其位置,并通过以下方式对其活动进行监管:
将确定效应物和抑制物。 GPI-PLC基因
将被克隆和测序,用于其生物合成的研究,
监管,并促进表征相应的
哺乳动物酶
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGE ALAN MARTIN CROSS其他文献
GEORGE ALAN MARTIN CROSS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGE ALAN MARTIN CROSS', 18)}}的其他基金
ACETYLATION OF H4K4 IS CELL CYCLE REGULATED & MEDIATED BY HAT3 IN T BRUCEI
H4K4 的乙酰化受细胞周期调节
- 批准号:
8169139 - 财政年份:2010
- 资助金额:
$ 23.33万 - 项目类别:
ACETYLATION OF H4K4 IS CELL CYCLE REGULATED & MEDIATED BY HAT3 IN T BRUCEI
H4K4 的乙酰化受细胞周期调节
- 批准号:
7954099 - 财政年份:2009
- 资助金额:
$ 23.33万 - 项目类别:
DNA BINDING PROTEINS & REGULATION OF SURFACE GLYCOPROTEINS IN TRYPANOSOMA BRUCE
DNA结合蛋白
- 批准号:
7954052 - 财政年份:2009
- 资助金额:
$ 23.33万 - 项目类别:
TELOMERE-DEPENDENT HETEROCHROMATIC EXPRESSIONSITE SILENCING IN T BRUCEI
布鲁斯锥虫中端粒依赖性异染色质表达位点沉默
- 批准号:
7722245 - 财政年份:2008
- 资助金额:
$ 23.33万 - 项目类别:
DNA BINDING PROTEINS & REGULATION OF SURFACE GLYCOPROTEINS IN TRYPANOSOMA BRUCE
DNA结合蛋白
- 批准号:
7722186 - 财政年份:2008
- 资助金额:
$ 23.33万 - 项目类别:
TELOMERE-DEPENDENT HETEROCHROMATIC EXPRESSIONSITE SILENCING IN T BRUCEI
布鲁斯锥虫中端粒依赖性异染色质表达位点沉默
- 批准号:
7355147 - 财政年份:2006
- 资助金额:
$ 23.33万 - 项目类别:
DNA BINDING PROTEINS & REGULATION OF SURFACE GLYCOPROTEINS IN TRYPANOSOMA BRUCE
DNA结合蛋白
- 批准号:
7355044 - 财政年份:2006
- 资助金额:
$ 23.33万 - 项目类别:
DEVELOPMENT OF GENETIC TOOLS FOR TRYPANOSOMA BRUCEI
布氏锥虫遗传工具的开发
- 批准号:
7017710 - 财政年份:2005
- 资助金额:
$ 23.33万 - 项目类别:
DEVELOPMENT OF GENETIC TOOLS FOR TRYPANOSOMA BRUCEI
布氏锥虫遗传工具的开发
- 批准号:
6902322 - 财政年份:2005
- 资助金额:
$ 23.33万 - 项目类别:
Telomere structure and function in Trypanosoma brucei
布氏锥虫端粒的结构和功能
- 批准号:
6843738 - 财政年份:2002
- 资助金额:
$ 23.33万 - 项目类别:
相似国自然基金
固本祛湿化瘀方调控银屑病角质细胞与初始T细胞Aspartate交互的机制研究
- 批准号:82305246
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Balancing redox homeostasis and the metabolic network through metabolite compartmentalisation: SLC25A13, aspartate, and the mitochondrion
通过代谢物区室平衡氧化还原稳态和代谢网络:SLC25A13、天冬氨酸和线粒体
- 批准号:
BB/Y002865/1 - 财政年份:2023
- 资助金额:
$ 23.33万 - 项目类别:
Research Grant
Aspartate beta-hydroxylase and DNA damage in chronic liver diseases
慢性肝病中的天冬氨酸 β-羟化酶和 DNA 损伤
- 批准号:
10667881 - 财政年份:2023
- 资助金额:
$ 23.33万 - 项目类别:
Regulation of brown fat fuel utilization by the malate-aspartate shuttle
苹果酸-天冬氨酸穿梭对棕色脂肪燃料利用的调节
- 批准号:
10712090 - 财政年份:2023
- 资助金额:
$ 23.33万 - 项目类别:
The Malate-Aspartate shuttle links dietary fatty acids to inflammatory responses in dendritic cells
苹果酸-天冬氨酸穿梭将膳食脂肪酸与树突状细胞的炎症反应联系起来
- 批准号:
10772912 - 财政年份:2023
- 资助金额:
$ 23.33万 - 项目类别:
The Malate-Aspartate shuttle links dietary fatty acids to inflammatory responses in dendritic cells
苹果酸-天冬氨酸穿梭将膳食脂肪酸与树突状细胞的炎症反应联系起来
- 批准号:
10528235 - 财政年份:2022
- 资助金额:
$ 23.33万 - 项目类别:
L-Aspartate signalling in the brain
大脑中的 L-天冬氨酸信号传导
- 批准号:
MR/W028964/1 - 财政年份:2022
- 资助金额:
$ 23.33万 - 项目类别:
Research Grant
Manipulating N-acetyl-L-aspartate transport to treat Canavan leukodystrophy
操纵 N-乙酰基-L-天冬氨酸转运来治疗 Canavan 脑白质营养不良
- 批准号:
10406711 - 财政年份:2022
- 资助金额:
$ 23.33万 - 项目类别:
Manipulating N-acetyl-L-aspartate transport to treat Canavan leukodystrophy
操纵 N-乙酰基-L-天冬氨酸转运来治疗 Canavan 脑白质营养不良
- 批准号:
10554428 - 财政年份:2022
- 资助金额:
$ 23.33万 - 项目类别:
Role of altered endoplasmic reticulum calcium regulation and the N-methyl-D-aspartate (NMDA) receptor signaling in cortico-striatal synaptic dysfunction: Opportunities for therapy in prodromal Huntington disease
改变的内质网钙调节和 N-甲基-D-天冬氨酸 (NMDA) 受体信号在皮质纹状体突触功能障碍中的作用:前驱期亨廷顿病的治疗机会
- 批准号:
443591 - 财政年份:2021
- 资助金额:
$ 23.33万 - 项目类别:
Operating Grants
A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-N-methyl-D-aspartate receptor (NMDAR) Encephalitis and Assess Markers of Disease
一项 2b 期、双盲、随机对照试验,旨在评估 Inebilizumab 在抗 N-甲基-D-天冬氨酸受体 (NMDAR) 脑炎中的活性和安全性并评估疾病标志物
- 批准号:
10185824 - 财政年份:2021
- 资助金额:
$ 23.33万 - 项目类别:














{{item.name}}会员




